Research ArticleCardiovascular
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide–High Angiotensin II–Induced Cardiovascular Injury
Luminita H. Pojoga, Tham M. Yao, Lauren A. Opsasnick, Waleed T. Siddiqui, Ossama M. Reslan, Gail K. Adler, Gordon H. Williams and Raouf A. Khalil
Journal of Pharmacology and Experimental Therapeutics October 2015, 355 (1) 32-47; DOI: https://doi.org/10.1124/jpet.115.226043
Luminita H. Pojoga
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Tham M. Yao
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Lauren A. Opsasnick
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Waleed T. Siddiqui
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Ossama M. Reslan
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Gail K. Adler
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Gordon H. Williams
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Raouf A. Khalil
Cardiovascular Endocrinology Section, Endocrinology, Diabetes, and Hypertension Division (L.H.P., T.M.Y., G.K.A., G.H.W.), and Division of Vascular and Endovascular Surgery (L.A.O., W.T.S., O.M.R., R.A.K.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
Mineralocorticoid Receptor, Cav-1, and Vascular eNOS
Luminita H. Pojoga, Tham M. Yao, Lauren A. Opsasnick, Waleed T. Siddiqui, Ossama M. Reslan, Gail K. Adler, Gordon H. Williams and Raouf A. Khalil
Journal of Pharmacology and Experimental Therapeutics October 1, 2015, 355 (1) 32-47; DOI: https://doi.org/10.1124/jpet.115.226043
Research ArticleCardiovascular
Mineralocorticoid Receptor, Cav-1, and Vascular eNOS
Luminita H. Pojoga, Tham M. Yao, Lauren A. Opsasnick, Waleed T. Siddiqui, Ossama M. Reslan, Gail K. Adler, Gordon H. Williams and Raouf A. Khalil
Journal of Pharmacology and Experimental Therapeutics October 1, 2015, 355 (1) 32-47; DOI: https://doi.org/10.1124/jpet.115.226043
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement